5 research outputs found
mtPIrtv in Andalusian 2-2-2016
mtPIrtv in Andalusian 2-2-201
Kaplan-Meier estimations of the efficacy as determined by on-treatment analysis applying different criteria for virological failure.
<p>Kaplan-Meier estimations of the efficacy as determined by on-treatment analysis applying different criteria for virological failure.</p
Percentages of detectable HIV-RNA determinations (red) according to virological behavior during the follow-up for ritonavir-boosted protease inhibitor monotherapy.
<p>Undetectable viremia (green).</p
Efficaccy rates.
<p>A) Efficacy rates according to the ritonavir-boosted protease inhibitor used by intention-to-treat and by on-treatment analyses. B) Virological efficacy rates according to virological failure (VF) defined as >200 copies/mL or C) >50 copies/mL or treatment change due to a single positive viremia, according to the presence or absence of previous VF on a non-boosted protease inhibitor- and/or ritonavir-boosted protease inhibitor-based regimen (PI/rtv). DRV/rtv, darunavir/ritonavir; LPV/rtv, lopinavir/ritonavir.</p